nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Anorexia—Auranofin—psoriatic arthritis	0.00949	0.00949	CcSEcCtD
Cefuroxime—Vaginal discharge—Methotrexate—psoriatic arthritis	0.00888	0.00888	CcSEcCtD
Cefuroxime—Dyspepsia—Auranofin—psoriatic arthritis	0.00876	0.00876	CcSEcCtD
Cefuroxime—Decreased appetite—Auranofin—psoriatic arthritis	0.00865	0.00865	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00814	0.00814	CcSEcCtD
Cefuroxime—Liver disorder—Methotrexate—psoriatic arthritis	0.00793	0.00793	CcSEcCtD
Cefuroxime—Urticaria—Auranofin—psoriatic arthritis	0.00791	0.00791	CcSEcCtD
Cefuroxime—Abdominal pain—Auranofin—psoriatic arthritis	0.00787	0.00787	CcSEcCtD
Cefuroxime—Candida infection—Triamcinolone—psoriatic arthritis	0.00781	0.00781	CcSEcCtD
Cefuroxime—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.00746	0.00746	CcSEcCtD
Cefuroxime—Pruritus—Auranofin—psoriatic arthritis	0.00704	0.00704	CcSEcCtD
Cefuroxime—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.00686	0.00686	CcSEcCtD
Cefuroxime—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.00685	0.00685	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.00681	0.00681	CcSEcCtD
Cefuroxime—Diarrhoea—Auranofin—psoriatic arthritis	0.00681	0.00681	CcSEcCtD
Cefuroxime—Vomiting—Auranofin—psoriatic arthritis	0.00633	0.00633	CcSEcCtD
Cefuroxime—Rash—Auranofin—psoriatic arthritis	0.00628	0.00628	CcSEcCtD
Cefuroxime—Dermatitis—Auranofin—psoriatic arthritis	0.00627	0.00627	CcSEcCtD
Cefuroxime—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Cefuroxime—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Cefuroxime—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Cefuroxime—Nausea—Auranofin—psoriatic arthritis	0.00591	0.00591	CcSEcCtD
Cefuroxime—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00571	0.00571	CcSEcCtD
Cefuroxime—Irritability—Methylprednisolone—psoriatic arthritis	0.00566	0.00566	CcSEcCtD
Cefuroxime—Hyperkinesia—Prednisone—psoriatic arthritis	0.00564	0.00564	CcSEcCtD
Cefuroxime—Thrombophlebitis—Prednisone—psoriatic arthritis	0.00542	0.00542	CcSEcCtD
Cefuroxime—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.0054	0.0054	CcSEcCtD
Cefuroxime—Irritability—Betamethasone—psoriatic arthritis	0.00514	0.00514	CcSEcCtD
Cefuroxime—Irritability—Dexamethasone—psoriatic arthritis	0.00514	0.00514	CcSEcCtD
Cefuroxime—Vaginal infection—Methotrexate—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Cefuroxime—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00507	0.00507	CcSEcCtD
Cefuroxime—Bronchitis—Triamcinolone—psoriatic arthritis	0.00494	0.00494	CcSEcCtD
Cefuroxime—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00489	0.00489	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00477	0.00477	CcSEcCtD
Cefuroxime—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Cefuroxime—Infestation—Methylprednisolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Cefuroxime—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisolone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Cefuroxime—Irritability—Prednisone—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisolone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Cefuroxime—Sweating—Methylprednisolone—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Cefuroxime—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00413	0.00413	CcSEcCtD
Cefuroxime—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Cefuroxime—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Cefuroxime—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Cefuroxime—Erythema—Prednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Cefuroxime—Neutropenia—Prednisone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Cefuroxime—Haemoglobin—Betamethasone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Cefuroxime—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Cefuroxime—Irritability—Methotrexate—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Cefuroxime—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Cefuroxime—Haemorrhage—Betamethasone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Cefuroxime—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Cefuroxime—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Cefuroxime—Erythema—Triamcinolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Cefuroxime—Erythema—Methylprednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Cefuroxime—Angioedema—Prednisolone—psoriatic arthritis	0.00355	0.00355	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Cefuroxime—Angiopathy—Dexamethasone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Cefuroxime—Angiopathy—Betamethasone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Cefuroxime—Convulsion—Prednisolone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Cefuroxime—Eosinophilia—Methotrexate—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Cefuroxime—Angioedema—Triamcinolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Cefuroxime—Angioedema—Methylprednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Cefuroxime—Erythema—Dexamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Cefuroxime—Erythema—Betamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Cefuroxime—Neutropenia—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Cefuroxime—Cough—Triamcinolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Cefuroxime—Convulsion—Triamcinolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Cefuroxime—Tachycardia—Prednisolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Cefuroxime—Convulsion—Methylprednisolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Cefuroxime—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.003	0.003	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Cefuroxime—Angioedema—Dexamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Cefuroxime—Angioedema—Betamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Cefuroxime—Angiopathy—Prednisone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Cefuroxime—Immune system disorder—Prednisone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Cefuroxime—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Cefuroxime—Sweating—Methotrexate—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Cefuroxime—Tachycardia—Triamcinolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Cefuroxime—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Cefuroxime—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Cefuroxime—Erythema—Prednisone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Cefuroxime—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Cefuroxime—Convulsion—Dexamethasone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Cefuroxime—Convulsion—Betamethasone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Cefuroxime—Pain—Prednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Cefuroxime—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Cefuroxime—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Cefuroxime—Dyspnoea—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Cefuroxime—Agitation—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Cefuroxime—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Cefuroxime—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Cefuroxime—Tachycardia—Betamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Cefuroxime—Tachycardia—Dexamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Cefuroxime—Angioedema—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Cefuroxime—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Cefuroxime—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Cefuroxime—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Cefuroxime—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Cefuroxime—Anorexia—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Cefuroxime—Anorexia—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Cefuroxime—Urticaria—Prednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Cefuroxime—Pain—Triamcinolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Cefuroxime—Convulsion—Prednisone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Cefuroxime—Chills—Methotrexate—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Cefuroxime—Arthralgia—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Cefuroxime—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Cefuroxime—Dyspepsia—Betamethasone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Cefuroxime—Urticaria—Triamcinolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Cefuroxime—Urticaria—Methylprednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Cefuroxime—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Cefuroxime—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Cefuroxime—Decreased appetite—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Cefuroxime—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Cefuroxime—Pain—Dexamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Cefuroxime—Pain—Betamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Cefuroxime—Tachycardia—Prednisone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Cefuroxime—Skin disorder—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Cefuroxime—Anorexia—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Cefuroxime—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Cefuroxime—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Cefuroxime—Urticaria—Betamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Cefuroxime—Urticaria—Dexamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Cefuroxime—Dizziness—Prednisolone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Cefuroxime—Body temperature increased—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Cefuroxime—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Cefuroxime—Abdominal pain—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Cefuroxime—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Cefuroxime—Pruritus—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Cefuroxime—Cough—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Cefuroxime—Pruritus—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Cefuroxime—Dyspepsia—Prednisone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Cefuroxime—Decreased appetite—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Cefuroxime—Rash—Prednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Cefuroxime—Dermatitis—Prednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.002	0.002	CcSEcCtD
Cefuroxime—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Cefuroxime—Headache—Prednisolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Cefuroxime—Dizziness—Triamcinolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Cefuroxime—Dizziness—Methylprednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Cefuroxime—Nausea—Prednisolone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Cefuroxime—Pruritus—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Cefuroxime—Pruritus—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefuroxime—Vomiting—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefuroxime—Vomiting—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Cefuroxime—Rash—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Cefuroxime—Dermatitis—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Cefuroxime—Rash—Methylprednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Cefuroxime—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefuroxime—Urticaria—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefuroxime—Headache—Triamcinolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefuroxime—Headache—Methylprednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Cefuroxime—Body temperature increased—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Cefuroxime—Abdominal pain—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Cefuroxime—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Cefuroxime—Diarrhoea—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Cefuroxime—Dizziness—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Cefuroxime—Dizziness—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Cefuroxime—Nausea—Triamcinolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Cefuroxime—Nausea—Methylprednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Cefuroxime—Vomiting—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefuroxime—Vomiting—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefuroxime—Rash—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefuroxime—Rash—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefuroxime—Dermatitis—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefuroxime—Dermatitis—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefuroxime—Headache—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefuroxime—Headache—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefuroxime—Pain—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Cefuroxime—Pruritus—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefuroxime—Diarrhoea—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Cefuroxime—Nausea—Betamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Cefuroxime—Nausea—Dexamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Cefuroxime—Dizziness—Prednisone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Cefuroxime—Vomiting—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Cefuroxime—Rash—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefuroxime—Dermatitis—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefuroxime—Headache—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Cefuroxime—Nausea—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Cefuroxime—Vomiting—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Cefuroxime—Rash—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Cefuroxime—Headache—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
